3[1]Bombardier C,Laine L,Recin Aet al Comparison of upper gastrointestinal Toxicity of Rofecoxib and naproxen in patients with RA[J].NEJM,2000,343:1520-1528.
4[2]Konstam MA,Weir MR,Reicin A et al:Cardivascular thrombotic events in controlled clinical trials of Rofecoxib[J].Circulation,2001,104:2280-2288.
5[3]Mamdani M,Rochon P,Juurlink DN et al:Effects of selective cox-2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly[J].Arch Int Med,2003,163:481-486.
6[4]Ray WA.Stein CM,Daugherty JR et al:Cox-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease[J].Lancet,2002,360:1071-1073.
7[5]Solomon DH,Schneeweiss S,Glynn RJ et al:Relationship between selective cox-2 inhibitors and acute myocardial infarction in older adults[J].Circulation,2004,109:2068-2073.
8[6]Graham DJ,Campen DH,Cheetham C et al:Risk of acute myocardial infarction and sudden cardiac death with use of cox-2 selective and non-selective[M].NSAIDss ACC,2004.
